DoD Prostate Cancer, Physician Research Award - Federal Grants

Funding Opportunity Overview

Opportunity NumberW81XWH-20-PCRP-PRA
Opportunity TitleDoD Prostate Cancer, Physician Research Award
Opportunity CategoryDiscretionary
Funding Instrument TypeGrant, Cooperative Agreement
Post DateMarch 18, 2020 (Wednesday)
Last Updated DateMarch 18, 2020 (Wednesday)
Close DateJune 18, 2020 (Thursday)

Funding Detail Description

The FY20 PCRP Physician Research Award supports a mentored research experience to prepare physicians with clinical duties and/or responsibilities for productive careers in prostate cancer research. The mentored physician is considered the Principal Investigator (PI) of the application. This award emphasizes equally the quality of the proposed research project and the career development of the PI, which should prepare physicians for careers in basic, population science, translational, or clinical prostate cancer research. All applications for the FY20 PCRP Physician Research Award are to be written by the PI, with appropriate direction from the Mentor(s).Key elements of this award mechanism are as follows:• Principal Investigator: Physicians with clinical duties and/or responsibilities who, at the application submission deadline, are either in the last year of an accredited graduate medical education program as a resident or fellow, or within 5 years of having initiated a faculty appointment (including Instructor positions), are eligible to apply. The PI must demonstrate a commitment to a career as an investigator at the forefront of prostate cancer research and clinical practice; however, the PI is not required to have previous prostate cancer research experience.• Mentor(s): This award requires the involvement of at least one designated Mentor with an established research program in prostate cancer, as evidenced by recent publications, active funding, and successful mentorship. In addition, the Mentor(s) must demonstrate a commitment to advancing the PI’s career in prostate cancer research.• Research Approach: Proposed research ideas are required to address one or more of the FY20 PCRP Overarching Challenges. The scientific rationale and experimental methodology should demonstrate in-depth analysis of the research problem presented. The feasibility of the research design and methods should be well defined, and a clear plan should be articulated as to how the proposed goals of the project can be achieved. The inclusion of preliminary data relevant to prostate cancer and the proposed project is encouraged but not required. Any preliminary data provided should be from the PI, Mentor(s), or member(s) of the collaborating team. Additionally, required resources should be identified and supported through documentation.• Researcher Development Plan: An individualized researcher development plan is required and should be prepared with appropriate guidance from the Mentor(s). The researcher development plan should include a clearly articulated strategy for acquiring the necessary skills, competence, and expertise that will enable the PI to successfully complete the proposed research project and foster the PI’s development as an independent prostate cancer researcher. An environment appropriate to the proposed mentoring and research project must be clearly described, although any deficiencies of resources and/or mentorship at the PI’s institution can be mitigated through collaboration(s) with other institutions. If the PI will be utilizing resources at another institution to successfully complete the proposed project, then the PI is strongly encouraged to designate a co-Mentor at the collaborating institution.• Impact: The proposed research must address and provide a solution to one or more of the FY20 PCRP Overarching Challenges and ultimately should have the potential to make a significant impact on the program’s mission of eliminating death from prostate cancer and enhancing the well-being of Service members, Veterans, and all the men and their families who are experiencing the impact of the disease.Investigators are strongly encouraged to incorporate the following components into their study design, where appropriate, in order to maximize the potential impact of the proposed research project: authentication of proposed cell lines; statistical rigor of preclinical animal experiments; and incorporation of experiments to assess clinical relevance and translatability of findings. As such, the PCRP-funded Prostate Cancer Biorepository Network (PCBN) (http://www.prostatebiorepository.org) and/or the North Carolina – Louisiana Prostate Cancer Project (PCaP) (https://pcap.bioinf.unc.edu) are important resources to consider if retrospectively collected human anatomical substances or correlated data are critical to the proposed studies. Investigators considering use of these or other resources are highly encouraged to provide a letter of support indicating access to and the availability of the desired resources to support the study. Studies utilizing data derived from large patient studies that include long-term health records, biospecimen repositories, and pre-existing research and apply state-of-the-art genomic and/or proteomic analysis, bioinformatics, and/or mathematical models to such data are also encouraged.Research involving human subjects is permitted under this funding opportunity, but is restricted to studies without clinical trials. Correlative studies associated with an existing clinical trial are particularly encouraged, provided they are determined to be no greater than minimal risk by the Institutional Review Board (IRB) of record and the U.S. Army Medical Research and Development Command (USAMRDC) Office of Research Protections (ORP), Human Research Protection Office (HRPO).Investigators seeking funding for a clinical trial are encouraged to consider submitting an application to the FY20 PCRP Clinical Trial Award (Funding Opportunity Number: W81XWH-20-PCRP-CTA).A Congressionally mandated Metastatic Cancer Task Force was formed with the purpose of identifying ways to help accelerate clinical and translational research aimed at extending the lives of advanced state and recurrent patients. As a member of the Metastatic Cancer Task Force, the CDMRP encourages applicants to review the recommendations (https://health.mil/Reference-Center/Congressional-Testimonies/2018/05/03/Metastatic-Cancer-Research) and submit research ideas to address these recommendations provided they are within the limitations of this funding opportunity and fit within the FY20 PCRP priorities.The anticipated direct costs budgeted for the entire period of performance for an FY20 PCRP Physician Research Award will not exceed $750,000. Refer to Section II.D.5, Funding Restrictions, for detailed funding information.Awards will be made no later than September 30, 2021. For additional information, refer to Section II.F.1, Federal Award Notices.The CDMRP expects to allot approximately $6M to fund approximately five FY20 PCRP Physician Research Award applications. Funding of applications received is contingent upon the availability of Federal funds for this program as well as the number of applications received, the quality and merit of the applications as evaluated by scientific and programmatic review, and the requirements of the Government. Funds to be obligated on any award resulting from this funding opportunity will be available for use for a limited time period based on the fiscal year of the funds. It is anticipated that awards made from this FY20 funding opportunity will be funded with FY20 funds, which will expire for use on September 30, 2026.

Funding Additional Information

Agency NameDept. of the Army -- USAMRAA
Important Dates
Post DateMarch 18, 2020 (Wednesday)
Close DateJune 18, 2020 (Thursday)
Last Updated DateMarch 18, 2020 (Wednesday)
Archive DateJuly 18, 2020 (Saturday)
Awards Detail
Estimated Total Program Funding$6,000,000
Expected Number Of Awards5
Cost Sharing or Matching RequirementNo

CFDA Numbers

Next CFDA (Catalog of Federal Domestic Assistance) numbers are associated to this grant.
  • 12.420 - Military Medical Research and Development

Categories of Funding Activities

Categories of Funding Activities

  • Science and Technology and other Research and Development

Category Explanation

  • No Additional Explanation Reported

Funding Eligibility

Eligible Applicants

  • Unrestricted (i.e., open to any type of entity below)
  • State governments
  • County governments
  • City or township governments
  • Special district governments
  • Independent school districts
  • Public and State controlled institutions of higher education
  • Native American tribal governments (Federally recognized)
  • Public housing authorities/Indian housing authorities
  • Native American tribal organizations (other than Federally recognized tribal governments)
  • Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education
  • Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education
  • Private institutions of higher education
  • Individuals
  • For-profit organizations other than small businesses
  • Small businesses
  • Others

Grantor Contact Information

Grantor ContactCDMRP Help Desk
Phone: 301-682-5507
Email: help@eBRAP.org
(CDMRP Help Desk)